North East and North Cumbria
ICS Formulary
 
back
3 Respiratory system

*Important*

The NENC ICB Respiratory Network recommends that all inhalers should be prescribed by brand for patient safety, to ensure that the correct device is dispensed to support correct technique and avoid patient confusion and medication errors.

Choice of inhaler device should be based on patient ability to use. Devices should be chosen based on availability for the type of drug to be prescribed and the patient’s ability to use it.

Refer to local guidelines for information on preferred options.

Note: All new patients should be started on the updated formulary choices as per local/national guidelines.

When inhalers are removed from the formulary, existing, stable, patients should continue to receive the non-formulary device. Treatment should not be changed unless a full face to face review has been conducted.

03-04-01 Sedating antihistamines

Chlorphenamine
First Choice

Green View adult BNF  View SPC online  View childrens BNF
Promethazine
Second Choice

Green View adult BNF  View SPC online  View childrens BNF
Hydroxyzine
Formulary
Link  MHRA Drug Safety Update (April 2015): Hydroxyzine (Atarax, Ucerax): risk of QT interval prolongation and Torsade de Pointes

Green View adult BNF  View SPC online  View childrens BNF
Alimemazine
Formulary
  • Hospital only for the following indications
    • Enteral sedation in paediatric ITU setting
    • Use in patients where promethazine has failed

  • Existing patients can continue to be prescribed in primary care until a treatment review has taken place  

Red View adult BNF  View SPC online  View childrens BNF